GGrantIndex
← Leaderboards

Maik Huettemann

Wayne State University

Google Scholar ↗PubMed ↗ORCID ↗
$6,887,189
Attributed
$11,591,079
Total exposure
7
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY2010–25
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,591,079 · 7

By mechanism

R01$7,685,769 · 5
U44$2,085,293 · 1
R42$1,820,017 · 1

Top collaborators

Most similar at Wayne State University

Same institution · by research overlap

Others in their field

Top investigators on “Mitochondria”

Research focus

MitochondriaProductionCytochrome C OxidaseReactive Oxygen SpeciesTissuesOxygenPreventGenerationsIn VivoElectron TransportLaboratoriesMembrane PotentialsMediatingRespirationMitochondrial MembraneCellular StressPhosphorylationStressOxidasesLightCellsBlood FlowNeuroprotectionFree Radicals

Grant awards (27)

Non-invasive infrared light therapy and medical device to treat spinal cord injury$561,974
R01 · FY2025 · NS · contact PI
Non-invasive mitochondrial modulation therapy for ischemic stroke$414,352
R01 · FY2025 · NS
Non-invasive infrared light therapy and medical device to treat spinal cord injury$586,525
R01 · FY2024 · NS · contact PI
Non-invasive mitochondrial modulation therapy for ischemic stroke$446,582
R01 · FY2024 · NS
Development and Testing of LUCID: A Therapeutic Device for Brain Injury Following Infant Cardiac Arrest$99,400
U44 · FY2024 · NS
Development and Testing of LUCID: A Therapeutic Device for Brain Injury Following Infant Cardiac Arrest$986,555
U44 · FY2023 · NS
Non-invasive mitochondrial modulation therapy for ischemic stroke$473,183
R01 · FY2023 · NS
Development and Testing of LUCID: A Therapeutic Device for Brain Injury Following Infant Cardiac Arrest$999,338
U44 · FY2022 · NS
Non-invasive mitochondrial modulation therapy for ischemic stroke$485,970
R01 · FY2022 · NS
Non-invasive mitochondrial modulation therapy for ischemic stroke$491,547
R01 · FY2021 · NS
Infant NeuroLUX: A Novel Non-invasive Therapeutic Device for Neonatal Hypoxic Brain Injury$768,981
R42 · FY2020 · NS
Control of Cell Respiration and Apoptosis by Phosphorylation of Cytochrome c$353,724
R01 · FY2020 · GM · contact PI
Infant NeuroLUX: A Novel Non-invasive Therapeutic Device for Neonatal Hypoxic Brain Injury$802,994
R42 · FY2019 · NS
Control of Cell Respiration and Apoptosis by Phosphorylation of Cytochrome c$367,410
R01 · FY2019 · GM · contact PI
Control of Cell Respiration and Apoptosis by Phosphorylation of Cytochrome c$367,410
R01 · FY2018 · GM · contact PI
Limiting brain reperfusion injury by controlling mitochondrial function$339,077
R01 · FY2018 · NS
Infant NeuroLUX: A Novel Non-invasive Therapeutic Device for Neonatal Hypoxic Brain Injury$248,042
R42 · FY2018 · NS
Control of Cell Respiration and Apoptosis by Phosphorylation of Cytochrome c$367,410
R01 · FY2017 · GM · contact PI
Limiting brain reperfusion injury by controlling mitochondrial function$200,883
R01 · FY2017 · NS
Limiting brain reperfusion injury by controlling mitochondrial function$135,992
R01 · FY2017 · NS
Limiting brain reperfusion injury by controlling mitochondrial function$336,692
R01 · FY2016 · NS · contact PI
Limiting brain reperfusion injury by controlling mitochondrial function$334,596
R01 · FY2015 · NS · contact PI
Regulation of Respiration and Apoptosis by Cytochrome c Phosphorylation.$285,912
R01 · FY2014 · GM · contact PI
Regulation of Respiration and Apoptosis by Cytochrome c Phosphorylation.$275,906
R01 · FY2013 · GM · contact PI
Regulation of Respiration and Apoptosis by Cytochrome c Phosphorylation.$285,912
R01 · FY2012 · GM · contact PI
Regulation of Respiration and Apoptosis by Cytochrome c Phosphorylation.$285,912
R01 · FY2011 · GM · contact PI
Regulation of Respiration and Apoptosis by Cytochrome c Phosphorylation.$288,800
R01 · FY2010 · GM · contact PI